Capital Fund Management S.A. Madrigal Pharmaceuticals, Inc. Transaction History

Capital Fund Management S.A.

  • $36 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$193.33 - $291.99 $625,809 - $945,171
3,237 Added 25.84%
15,762 $4.42 Million
Q1 2024

May 15, 2024
SELL
$171.37 - $283.23 $1.48 Million - $2.45 Million
-8,649 Reduced 40.85%
12,525 $3.34 Million
Q4 2023

Feb 14, 2024
BUY
$120.4 - $237.13 $2.55 Million - $5.02 Million
21,174 New
21,174 $4.9 Million
Q2 2023

Aug 14, 2023
BUY
$203.88 - $312.0 $3.71 Million - $5.68 Million
18,205 New
18,205 $4.21 Million

Others Institutions Holding MDGL

# of Institutions
296
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.94B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email